The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II randomized, double-blind trial of a polyvalent vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian (EOC), fallopian tube, or peritoneal cancer who are in second or third complete remission.
 
Paul Sabbatini
Research Funding - Bristol-Myers Squibb (Inst); Ludwig Institute for Cancer Research (Inst); OncoMed (Inst)
 
Lee-may Chen
No Relationships to Disclose
 
Joseph A. Lucci
No Relationships to Disclose
 
Kian Behbakht
No Relationships to Disclose
 
Nicola M. Spirtos
No Relationships to Disclose
 
Carolyn Muller
Research Funding - Amgen (Inst); Pfizer (Inst)
 
Benedict B. Benigno
No Relationships to Disclose
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Eisai; Roche/Genentech
Speakers' Bureau - Genentech/Roche
Research Funding - AstraZeneca
 
Emily Berry
No Relationships to Disclose
 
Krishnansu Sujata Tewari
No Relationships to Disclose
 
Parviz Hanjani
No Relationships to Disclose
 
Wei Deng
No Relationships to Disclose
 
Heather A. Lankes
No Relationships to Disclose
 
Carol Aghajanian
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Abbvie; AstraZeneca